Pharma Dynamics is the country’s leader in cardiovascular medication since 2012 - both in terms of value and volume – and is the fastest growing generic pharmaceutical company in South Africa. The organisation celebrates 19 years of improving the quality of life for South Africans after entrenching its mark in the industry with the launch of Amloc and Bilocor – SA’s two top selling anti-hypertensives. Today, Pharma Dynamics is active in more than 30 therapeutic areas, which include Heart Health, Diabetes, Central Nervous System (CNS), Female Healthcare, Antimicrobial, Pain, and Digestive Disorders categories. Pharma Dynamics also supplies a range of over-the-counter (OTC) products, including leading South African brands for cold and flu, allergies, heartburn and immune boosters, which are recommended and prescribed by leading doctors and pharmacists nationwide. The acquisition of Pharma Dynamics by Lupin Laboratories – the 7th largest global generics company – enables the organisation to harness the potential of global sourcing as a way to further reduce the cost of medicine. As a result, Pharma Dynamics will expand its operations in the areas of anti-infective, biosimilars, complex molecules and specialty products. Over and above the supply of medication, we at Pharma Dynamics believe in going beyond the pill and we are inspired by our potential to improve the quality of life for South Africans. That is why we have invested and implemented sustainable patient support and education programmes that assist healthcare providers in improving patient outcomes in diseases areas such as hypertension, diabetes, and depression, amongst others. These programmes are aimed at patient and individual empowerment to improve healthcare provision through prevention and lifestyle management.